인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
DBpia AI
AI 에이전트
AI 아이디어
AI 리더
AI 뷰어
Citeasy
크롬 서지관리 다운로드
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
학술저널
DBpia Top 0.5%
Full-text XML
오류 신고하기해당 페이지 내 제목·저자·목차·페이지정보가 잘못된 경우 알려주세요!
식물 유래 항암제와 생산 개선을 위한 식물 합성생물학 연구 동향 Plant-derived Anticancer Drugs and Research Trends of Plant Synthetic Biology for Production Improvement
논문 기본 정보
- 저자정보
- 발행연도
- 2022.12
- 수록면
- 462 - 480 (19page)
- DOI
- 10.7783/KJMCS.2022.30.6.462
식물 유래 항암제와 생산 개선을 위한 식물 합성생물학 연구 동향
초록·키워드
Background: Plants are rich in phytochemicals, and their bioactive compounds have been employed in traditional medicine since ancient times. A variety of medicinal plant species and phytochemicals have been used to treat a wide range of chronic diseases, most notably, cancer.
Methods and Results: As the global prevalence of cancer increases, numerous investigations are being carried out to develop phytochemical-based medicines. For example, paclitaxel, camptothecin, vinca alkaloids, and podophyllotoxin are US Food and Drug Administration (FDA)-approved anticancer drugs derived from plants. However, plants contain only trace amounts of phytochemicals, which makes it difficult to supply them continuously. Moreover, their complicated structures hinder their ability to produce large quantities of chemicals for commercial use. Recently, researchers have developed a number of biotechnological platforms to enhance the production of phytochmicals.
Conclusions: In this review, we summarize the current status of four FDA-approved anticancer drugs derived from plants and provide plant biotechnology strategies, including synthetic biology, to facilitate their production.
Methods and Results: As the global prevalence of cancer increases, numerous investigations are being carried out to develop phytochemical-based medicines. For example, paclitaxel, camptothecin, vinca alkaloids, and podophyllotoxin are US Food and Drug Administration (FDA)-approved anticancer drugs derived from plants. However, plants contain only trace amounts of phytochemicals, which makes it difficult to supply them continuously. Moreover, their complicated structures hinder their ability to produce large quantities of chemicals for commercial use. Recently, researchers have developed a number of biotechnological platforms to enhance the production of phytochmicals.
Conclusions: In this review, we summarize the current status of four FDA-approved anticancer drugs derived from plants and provide plant biotechnology strategies, including synthetic biology, to facilitate their production.
본문·목차
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
최근 본 자료 전체보기
UCI(KEPA) : I410-ECN-0101-2023-524-000309887
